What do we mean when we suggest that outcome measures are the key to optimizing upper-limb prosthetic rehabilitation? The answers to this question are important to a wide range of stakeholders, including current and future patients, clinicians and researchers, prosthetic manufacturers, private insurers, workers’ compensation providers, the U. S. Department of Defense, and government-funded insurance programs.
Support authors and subscribe to content.
Subscribe to read the entire article.
Login if you have purchased
Subscribe
Gain access to all Premium articles.Your support helps keep The O&P EDGE online.
